Sector: Pharma
Sanofi and GSK COVID-19 vaccine candidate demonstrates strong immune responses across all adult age groups in Phase 2 trial
Sanofi and GSK COVID-19 vaccine candidate demonstrates strong immune responses across all adultage groups in Phase 2 trial Adjuvanted recombinant COVID-19 vaccine candidate triggered strong neutralizing antibody responses in all adult age groups High immune response after a single dose in patients with prior infection shows strong booster potential Global Phase 3 study expected to … Read more
Over 300 pharma, healthcare companies eligible for new Covid loans
As many as 354 Crisil-rated companies, predominantly pharmaceutical firms and hospitals, with an aggregate bank exposure of Rs 40,000 crore will be eligible for Covid loans from lenders under RBI’s liquidity facility. Though pharmaceutical firms account for 68 per cent of rated bank exposure, hospitals (about 24 per cent of rated exposure) are likely … Read more
Vaccitech, startup behind Oxford Covid vaccine tech, falls 20% in Nasdaq debut
American depositary shares of Vaccitech fell nearly 20% in their Nasdaq debut on Friday, giving the co-inventor of the Covid-19 vaccine developed by AstraZeneca Plc and Oxford University a market value of about $464 million. The biotech firm’s shares opened at $13.62, below the initial public offering (IPO) price of $17 apiece for 6.5 million … Read more
Zandu Pharmaceuticals: Bought for Rs 12.5 cr, sold at Rs 2000 cr; How Zandu scion scaled API business 160 times in 12 years
Remember Zandu balm? Back in 2008, Nihar Parikh had no inkling about the ferocity of the takeover battle between his family and Kolkata based who had raided their family’s crown jewel – the 10 year old OTC and ayurveda company Zandu Pharmaceuticals, makers of the eponymous pain relief balm, chyawanprash etc. Like most 22-year olds, … Read more
Baillie Gifford scored a gain of $27.6 billion by betting early on Moderna, Tesla and Alibaba. Its team breaks down the 3-part strategy it uses to discover transformational stocks that offer…
Edinburgh-based firm Baillie Gifford took early bets in some of last year’s biggest winners. Tesla, Moderna and Alibaba have made the firm profits of around $27.6 billion – Bloomberg data. The Baillie Gifford team told Insider their 3 tips to making a success of active investing. Visit the Business section of Insider for more stories. … Read more
SII CEO Adar Poonawalla warns of delays in vaccine production as US prioritizes Pfizer
The head of the world’s biggest vaccine maker and the World Health Organization’s chief scientist said manufacturers of coronavirus shots face a global shortage of the raw materials needed to churn out the inoculations. Adar Poonawalla, the chief executive officer of the Serum Institute of India Ltd. — which is licensed to produce hundreds of … Read more
Top Stocks: How a Rs 10,000 investment in these stocks grew over the decades | India Business News
What makes companies stock market favourites? They dare to dream. As equity indices scaled fresh peaks in 2021, here’s how an initial push of Rs 10,000 fared over the decades in the below mentioned stocks. IT stocks Infy: Rs 1.5 crore (1995*) Infosys is the stuff of middle class dreams. It was founded as an … Read more
Pharma, FMCG push hiring activity in India by 24% in September: Naukri.com
Driven by industries like pharma, fast-moving consumer goods, education and IT, hiring activity in India saw a growth of 24 per cent in September compared to the previous month, according to a new report by job portal Naukri on Monday. Further opening up of the economy with unlock measures and increased mobility has led to … Read more